rhGAD65

DRUG2 trials

Sponsors

Diamyd Therapeutics AB

Conditions

Type 1 Diabetes Mellitus

Phase 3

A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)

TerminatedNCT00723411

Diamyd Therapeutics ABType 1 Diabetes Mellitus

Start: 2008-07-31End: 2011-08-31Updated: 2011-10-10

A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT

TerminatedNCT00751842

Diamyd Therapeutics ABType 1 Diabetes Mellitus

Start: 2008-09-30End: 2012-07-31Updated: 2012-10-10

Related Papers

Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD<sub>65</sub>-induced immune response.

2017-03-299 citations

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

2012-02-01237 citations